In 2022, the endodontic devices market size was estimated to be worth USD 1.2 billion. The endodontic devices market is expected to increase from USD 1.25 billion in 2023 to USD 1.84 billion by 2032, with a compound annual growth rate (CAGR) of 4.90% over the forecast period (2023-2032). The study also discusses and examines the effect of the Covid-19 outbreak on the endodontic devices market, including future opportunities and threats, drivers, and risks.
Endodontics is a dental problem-related study (practice). Endodontic treatment is also referred to as root canal treatment, which includes the prevention, diagnosis, and treatment of illnesses and injuries in the tooth.
Market Dynamics
Increasing globalization and the introduction of emerging technologies in dental care lead to doubling the demand for endodontic devices. The key factors influencing this demand are the rise in the prevalence of dental problems, microbial infected teeth, growth in the aging population, and an increase in the incidence of oral cancer among the people.
Nonetheless, factors such as high treatment costs, illicit sales of dental products, and treatment-related complications can hinder the growth of the market during the review period.
Market Segmentation
The global market for endodontic devices market has been segmented based on product and end-user.
By product, the global market for endodontic devices market has been segmented into consumables and instruments. By consumables, the market is categorized into endodontic burs, obturation filling materials, endodontic files & shaper, irrigating solution & lubricants, and others. Instruments segment is further sub-segmented into apex locators, endodontic scalers, machine-assisted obturation systems, handpieces, and endodontic lasers.
By the end-user, the global market for endodontic devices market has been categorized into dental clinics, laboratories, dental hospitals, dental academic, and research institutes.
Regional Analysis
Region-wise, the global market for endodontic devices market trend has been segmented into the Americas, Europe, Asia Pacific, and the Middle East and Africa.
The Americas leads the global market for endodontic devices due to the increasing incidence of dental infections due to changing eating habits, increased prevalence of dental diseases, and increased accident rates are also crucial factors driving the market for endodontic devices.
It was reported that Europe was second in the global market for endodontic devices in 2017. Increased demand for root canal treatment and damage or infection of the teeth is expected to fuel market growth.
The Asia Pacific was the fastest-growing region on the global market for endodontic devices in 2017. Factors such as an increase in dental procedures, an increase in the world’s aging population, an increase in the healthcare industry, and the emergence of new treatment methods for dental problems drive the demand in this area.
The Middle East and Africa have the least market share in the global market for endodontic devices. The existence of weak economies and a low per capita income, particularly in the African region, make the market lag within the area. The bulk of the market share in this area is expected to be held by the Middle East due to increased government support for healthcare and the involvement of developed economies such as the UAE, Kuwait, Dubai, and others.
Key Players
Some of the leading participants identified MRFR in the global endodontic devices market are DENTSPLY SIRONA, COLTENE Holding, Danaher Corporation, Ivoclar Vivadent, Septodont, Brasseler USA, MICRO-MEGA, DiaDent Group International, Kerr Corporation, Surtex Instruments Limited, Ultradent Products, Davis Schottlander & Davis Ltd, Hu-Friedy Mfg. Co., LLC, and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Synopsis
The fertility medicine and surgery market is anticipated to reach USD 2.21 billion by 2030, growing at a CAGR of 9.50% from 2022 to 2030. Some of the major aspects influencing this growth include health factors such as a spike in global infertility rates, increased gamete donations, obesity, and delayed pregnancies. Some economic factors, such as a rise in disposable incomes and healthcare expenditure around the world, are other crucial factors growing the market. Further, a sedentary lifestyle across the globe is the leading cause of rising infertility, which appears to be boosting the demand for treatment and is driving the market growth. In addition to this, a shift from the traditional cultural viewpoint, the rising age of the average pregnant woman, increased health problems such as infertility and obesity, and a rampant surge in sexually transmitted diseases is pushing the boundaries for great expansion in the global market for fertility treatment. Thus, it is seen that increasing awareness about medical procedures is creating plenty of opportunities for the future of family planning. However, negative externalities such as high cost of treatment and medical complications may challenge the market growth during the forecast period.
Regional Analysis
The global fertility drug and surgery market can be segmented on the basis of drug, underlying cause, end-user, procedures, and region.
On the basis of drugs, the global fertility drug and surgery market can be segmented on the basis of clomiphene citrate, letrozole, Serophene, hormone treatment, gonadotrophins.
On the basis of the underlying cause, the global fertility drug and surgery market can be segmented on the basis of male and female
On the basis of end-user, the global fertility drug and surgery market can be segmented on the basis of fertility clinics, hospitals, clinical research institutes, and others.
On the basis of procedures, the global fertility drug and surgery market can be segmented on the basis of hysteroscopy, laparoscopy and robotic laparoscopy, laparotomy/open surgery, egg retrieval, varicocelectomy, vasectomy reversal (vasovasostomy or vasoepididymostomy), sperm retrieval (epididymal aspiration)
On the basis of region, the global fertility drug and surgery market research can be segmented on the basis of the Americas, Europe, Asia-Pacific, and the Middle East and Africa.
Regional Analysis
The global market for fertility drugs and surgery is dominated by the Americas – owing to increasing infertility, obesity, and delayed pregnancies. From an economic perspective, an increase in the disposable income of an average American household adds to the boost in market growth. This trend is closely followed by Europe, who stood second in 2017 in the global fertility drug and surgery market.
On the other hand, Asia Pacific happens to be the fastest-growing region for this market. It is driven by factors such as increasing awareness amongst people and growing healthcare infrastructure in this region.
Lastly, the Middle East and Africa face issues such as abject poverty and failing economics, making the market lag within this region and causing it to have the least share in this market. However, between the Middle East and Africa, the former seems to hold a bigger portion of the market share owing to increased government funding in healthcare programs and the presence of more developed economies including UAE, Kuwait, and Saudi Arabia
Key Players
The established players of the global fertility drug and surgery market are Baxter Healthcare Corporation, Eli Lilly, Ferring Pharmaceuticals, Inc., Noven Pharmaceuticalorganon, Inc., Merck & Co. Pharmaceutical Company, Janssen Pharmaceuticals Inc., Pfizer, Inc., Procter & Gamble Pharmaceuticals, Personal Products Company, Emd Serono, Inc., and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Overview:
The Fetal Bovine Serum Market Size was assessed at USD 0.9 billion in 2022 and is expected to expand from USD 0.95 billion in 2023 to USD 1.5 billion by 2030, with a compound annual growth rate (CAGR) of 5.7% during the forecast period (2023– 2030). The global market is expecting strong tailwinds from improvements in the research and development sector, increased funding from governments and private bodies, heightened demand from various traditional serum users, and its hike in expansion in the emerging nations.
However, the fetal bovine serum market may find it a bit difficult to grow in the coming years due to the financial crisis triggered by COVID-19.
Segmentation:
The global fetal bovine serum market insights, as in the report released by MRFR, has been segmented by application, product type, and end user. These segments hold various market dynamics and factors known for their influential contributions in furthering the market concerns. A deep look into these could reveal various pointers that can help companies in planning their moves.
By product type, the report on the fetal bovine serum market can be segmented into Charcoal Stripped, Dialyzed Fetal Bovine Serum (FBS), Chromatographic, Stem Cell, Exosome Depleted, and others. The stem cell segment has sub-segments like embryonic stem cells qualified, and mesenchymal stem cell qualified.
By application, the report discussing the fetal bovine serum market can be segmented into cell culture media, drug discovery, human & animal vaccine production, diagnostics, in-vitro fertilization, and others. The drug discovery segment would increase its intake due to the recent changes in market dynamics.
By end user, the report studies the market on the basis of pharmaceutical, biotechnology, research & academic institutes, and others. The pharmaceutical sector is expected to provide substantial market back up to the global market.
Regional Analysis:
The Americas has a chance to observe high growth in the market using which it would continue its domination. The regional market is slated to benefit from the presence of the US and Canada. These two countries are known for their extensive market contributions as their pharmaceutical sectors are providing various supports to the regional market. Europe would benefit from its extensive research and development facilities. Countries from the region would invest substantially in developing new drugs. In the Asia Pacific region, the inclusion of latest technologies in various sectors to boost industrial growth would ease the path for market percolation.
Competitive Landscape:
The fetal bovine serum market share is all set to benefit from the strategic moves controlled by Merck KGaA, HiMedia Laboratories, Atlanta Biologicals Inc., Bovogen Biologicals Pty Ltd, Tissue Culture Biologicals, TCS Biosciences Ltd, RThermo Fisher Scientific, Rocky Mountain Biologicals, GE Healthcare, PAN-Biotech, Bio-Techne, Nucleus Biologics, Access Biologicals, Animal Technologies Inc., Corning Incorporated, J R Scientific Inc., Biological Industries, Wisent Inc, Moregate Biotech, Zhejiang Tianhang Biotechnology Co. Ltd., and others. MRFR listed these companies and included their recent contributions to the market to understand the momentum of the market. This would also help in gauging market reactions to various pointers and as its result, strategy-devising processes would become simpler.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
In 2022, the market for minimally invasive surgery devices was estimated to be USD 12.9 billion. The minimally invasive surgery devices market is expected to increase from USD 14.06 billion in 2023 to USD 28.483 billion by 2032, with a compound yearly growth rate (CAGR) of 9.20% over the forecast period (2023-2032).
Minimally-invasive surgeries are far less traumatic than conventional open surgeries. Traditional surgeries with conventional laparoscopic instruments can be traumatic and intricate. Minimally-invasive laparoscopic cameras are inserted through smaller incisions, and special smaller instruments are used to perform the surgery.
The market for minimally-invasive surgical instruments is growing at a staggering pace throughout the world. The factors impelling the growth of this market are the rise in the geriatric population, and, as a consequence, there is an increase in the number of surgeries performed in this section of the people.
Market Dynamics
Significant factors influencing the market growth include rising economic growth, growing geriatric population, increasing prevalence of chronic diseases. According to the World Health Organization (WHO), the amount of the burden of chronic diseases is expected to rise to 60% by 2020, and 79% of deaths due to such diseases are expected to occur in developing countries.
The demand for minimally-invasive surgery devices is increasing due the significant benefits associated with minimal surgical procedures, such as small or no incisions, short hospital stay, less pain, quick recovery time, less scarring and reduced blood loss. The increasing popularity of minimally-invasive non-robotic surgery has boosted the global market for minimally-invasive surgical devices.
Nevertheless, factors such as stringent government regulations and high-cost devices for surgery are hindering the growth of the market.
Segmentation
The global market for minimally-invasive surgery devices has been segmented into type, application, and end-user.
Based on the type, the global market for minimally-invasive surgery devices outlook has been segmented into handheld instruments, inflation devices, cutter instruments, guiding devices, electrosurgical devices, auxiliary devices, and others.
Based on the application, the global market for minimally-invasive surgery devices has been segmented into cardiac surgery, gastrointestinal surgery, orthopedic surgery, vascular surgery, gynecological surgery, urological surgery, thoracic surgery, cosmetic surgery, dental surgery, and others.
Based on the end-user, the global market for minimally-invasive surgery devices has been segmented into hospitals & clinics, ambulatory surgical centers, and others.
Regional Analysis
The global minimally-invasive surgery devices market report, by region, has been segmented into the Americas, Europe, Asia Pacific, and the Middle East & Africa.
The Americas are expected to dominate the global market for minimally-invasive surgery devices due to the existence of a large patient population, high healthcare expenditure, well-developed technologies, and leading players. Moreover, as per the Population Reference Bureau, the number of Americans over the age of 65 is estimated to be more than double from 46 million in 2014 to over 98 million by 2060. Geriatric people are more vulnerable to multiple diseases.
Europe is set to retain the second-largest position in the global market for minimally-invasive surgery devices.
The Asia Pacific is the fastest-growing market for minimally-invasive surgery devices due to the increasing need for better monitoring devices, the rapid improvement of technology, and the presence of a large patient pool. In addition, the existence of a large geriatric population and enormous opportunities for the development of this market led to market growth.
The market for minimally-invasive surgery devices in the Middle East and Africa is expected to expand at a steady rate.
Key Players
Some of the leading participants in the global minimally-invasive surgery devices market are Abbott, GE Healthcare, Medtronic, Inc, Ethicon, Inc., DePuy Synthes, Intuitive Surgical, Inc, Siemens Healthcare GmbH ArthroCare Corporation, Fortimedix Surgical, NuVasive, Inc., Biomet, Inc, Norwood Medical, KEBOMED Europe AG, Freudenberg Medical, and others.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Overview:
The Soft Tissue Repair Market is expected to reach USD 13.43 billion by 2030, growing at a 4.20% CAGR between 2022 and 2030. Market Research Future (MRFR) studied several changes and included factors like the rising cases of sports-related injuries and the inclusion of top-notch technologies as major growth-inducers. In addition, reimbursement policies, untapped potential in emerging countries, products in the pipeline for approval, and healthcare expenditure are expected to make an impact on the market.
Segmentation:
The global soft tissue repair market has been segmented on the basis of product, application, and end user. These segments have a lot of data related to various factors, which can inspire strategies that could make the market more sustainable.
By product, soft tissue repair market trend has been segmented on the basis of tissue patch/match, a laparoscopic instrument, fixation products, and others. The fixation products segment includes suture anchors, suture, and interference screw. The tissue patch/match segment encompasses biological and synthetic. The biological segment has been studied on the basis of allograft and xenograft.
By application, the study on the market includes skin repair, hernia repair, orthopedic surgery, breast reconstruction, dental reconstruction, cardiovascular surgery, vaginal sling repair, and others. The dental reconstruction segment is getting backed substantially. A rise in demand for aesthetic changes is boosting the breast reconstruction segment.
By end user, the market includes hospitals, clinics, research & academic institutes, and others.
Regional Analysis:
The Americas would take charge of the global market as the market is getting backing in the Northern part due to the rising expenditure in research and development. Two countries, the US and Canada, are impacting the most. Their superlative infrastructure is also providing much support to the market.
Competitive Landscape:
Arthrex, Inc., Integra LifeScience Corporation, Stryker Corporation, C.R. Bard, Inc., Allergan Plc., Athersys, Inc., Depuy Synthes, Smith & Nephew plc, Organogenesis Inc., Zimmer Biomet Holdings, Inc., CryoLife, Inc., Medtronic Plc., U.S. Stem Cell, Inc., Wright Medical Group, Inc., Lifenet Health, Inc., American Medical Systems Inc., Isto Biologics, and others are companies that got involved in the soft tissue repair market. Most of these companies are planning changes in their strategic moves and some have already started implementing them to sustain during the forecast period. These moves often span across mergers, collaborations, product launching, branding, better funding for research and development, and others. MRFR’s attempt to dig deep into the market to find out various changes is getting reflected in its efforts to map the recent steps taken by these companies, which may help in charting a proper course in the coming days.
However, various states are lifting the lockdowns, which would inspire people to go out and hit the gym or start getting involved in sports. These two are major traction providers for the soft tissue repair market size. Such a change would also create scope for treatment-associated products to plan their strategies accordingly.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scenario
The hospital beds market size was valued at USD 3.1 billion in 2021 and is expected to rise from USD 3.33 billion in 2022 to USD 6.38 billion by 2032, with a compound annual growth rate (CAGR) of 7.5% over the forecast period (2023-2032). However, expensive hospital beds, such as semi-electric and electric beds can counter the market rise in the forecast period.
The increase in number of admissions in hospitals and surge in demand for health care services can promote expansion of the market in the assessment period. Hospital beds aid in positioning that body that has greater feasibility over regular home bed that can promote expansion of the market in years come. The increase in number of ECG machines and their need can favor expansion of the market in the analysis period. The availability of advanced type hospital beds can also promote expansion of the market in the study period. The increase in prevalence of different chronic malaises and rise in number of ambulatory centers can promote expansion of the market in the years ahead.
Market Segmentation
The segment assessment for the global hospital beds market is done by type, end-users, and power.
The type-based segments of the global hospital beds market are psychiatric & bariatric care, acute care, and long-term care among others. Maternity beds and rehabilitation beds are among these others. The Acute care bed segment can earn about 58.7% share of the worldwide hospital beds market by the end of the review period.
The power-based segments of the hospital beds are semi-electric bed, electric bed, and manual bed.
The end-users-based segments of the hospital beds market are ambulatory, hospitals, and clinics among others.
Regional Analysis
As per MRFR regional assessment, the hospital bed market in Europe can secure the largest share of the worldwide market. Europe hospital beds market trend can valued above USD 916.6 Mn and rise at 5.5% CAGR across the analysis period. In Asia Pacific, the hospital bed market can surge at 5.9% CAGR through the forecast period. Europe can dominate the worldwide hospital bed market due to hike in healthcare spending, well-developed healthcare sector, favorable reimbursement policies, and rise in government support can favor expansion of the market through the assessment period. The U.K. can rise at decent pace and earn greater than USD 916.6 Mn at 5.5% CAGR through the forecast period. In the Americas, the well-developed healthcare ecosystem, huge geriatric population, and hike in investment in healthcare research and development can support expansion of the regional hospital beds market. In Asia Pacific, the hospital beds market can surge at decent pace. In the Middle East and Africa, decline in healthcare spending and no easy access to limited technologies can support expansion of the market in the analysis period.
Key Players
Hill-Rom Holdings, Gendron Inc., Invacare Corporation, Stryker Corporation, Linet spol. s r.o., Paramount Bed Holdings Co., Ltd., and Getinge AB are some reputed names in the worldwide hospital beds market that are listed by MRFR. The report offered by MRFR on Hospital Beds Market can hold valuable insights on the market that are acquired by extensive research that is both qualitative and quantitative. Involvement of Industry experts and opinion from global leader aid in preparing on deeper insights into the market and its performance along the analysis period. The report offers clear picture of market scenario that includes historical interpretation and projects market size. Technological advancement, and other governing factors, such as; macroeconomic can provide information of the market for investors.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Overview
The hospital furniture market was valued at USD 7.8 billion in 2021 and is expected to expand from USD 8.5 billion in 2022 to USD 18.9 billion by 2032, with a compound yearly growth rate (CAGR) of 9.7% over the forecast period (2022-2032).
An increasing number of hospitals and clinics around the globe are the major factors responsible for the growth of the global hospital furniture markets share. Increasing the prevalence of various chronic diseases and increasing patient expectations towards the hospital infrastructure also contributed to market growth.
In contrast, the high cost and need for long-life furniture have hampered market growth. The incidence of chronic diseases, including cancer and diabetes, is growing, which is likely to create an impact on global market growth during the prognosis period.
Over the past five months, MRFR has observed the massive impact of novel coronavirus on the lives of people. This also impacted various sectors across the world, ultimately impacting the global economy. Some industries have experienced negative growth, while some industries have experienced tremendous demand during this period and have generated massive revenues.
It would be misleading to assume that all healthcare facilities around the globe have sufficient medical services in order to serve the specific patient population until COVID-19. The global hospital furniture market research is driven primarily by the growing demand from emerging economies to develop their healthcare sector and increased investment by private entities in the healthcare sector, leading to increased demand for premium, expensive hospital furniture offering the latest in ergonomics and comfort.
Segmentation
The global hospital furniture market is segmented on the basis of type, into hospital beds, bedside tables, OT tables, instrument stands, stretchers, chairs, trolley, scrub sinks, waste containers, and others. The hospitable bed segment is projected to lead the global hospital furniture market during the forecast period.
On the basis of application, the global market has been segmented into the patient’s furniture and staff’s physician furniture, furniture.
Based on end-users, the market is segmented into hospitals, diagnostic centers, clinics, and others. The segment of hospitals dominated the world market for hospital furniture, and the trend is expected to continue over the review period.
Regional analysis
The region-based hospital furniture industry research includes the Americas, Europe, Asia Pacific (APAC), and Middle East & Africa (MEA).
The Americas holds the largest volume of market share. The country has excellent healthcare services and is investing extensively in preserving the same. These factors have impacted growth in the market.
Europe is now experiencing a major transition due to characteristics similar to those of the Americas. The APAC region is registering significant growth, and during the forecast period, it would be the fastest. Emerging countries and states are investing aggressively on improving their health care system are also taking the requisite steps to improve the healthcare section. In addition, several countries in the area are emerging as a medical hub which gives the market considerable traction.
Competitive Dashboard
The eminent players of the global market are Narang Medical (India), Bio Medical Solutions (India), KI (US), GPC Medical (India), Chang Gung Medical Technology (China), Anetic Aid Limited (UK), DRE INC (US), The Brewer Company (US), GPC Medical Ltd (India), Hill-Rom (US), Stryker Corporation (US), Beaver Healthcare Equipment (UK), Renray Healthcare Ltd. (UK), Moore Medical LLC (US), Bristol Maid Hospital Metalcraft (UK), Beaver Healthcare Equipment (UK).
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Scope
The urological devices market was valued at USD 36.5 billion in 2022 and is expected to rise from USD 37.96 billion in 2023 to USD 48.5 billion by 2032, with a compound annual growth rate (CAGR) of 4% between 2023 and 2032.
Growth Drivers and Challenges
Notable rise in the number of patients suffering from diabetes and high blood pressure (hypertension) has fostered the demand for advanced urology devices in recent years. These diseases are known for causing kidney failure. The American Kidney Fund’s recent studies show that nearly 40.4% of the overall kidney failure cases worldwide are caused by diabetes, while 30% is the result of high blood pressure. Cases of diabetes and hypertension have been surging exponentially in developing countries across Middle East and Asia Pacific, considering the prevalence of stressful and hectic lifestyle and the burgeoning elderly populace.
Another growth rendering factor can be the expanding geriatric population prone to kidney and urinary disorders. The demand for urology devices is further elevated by the mounting demand for minimally invasive procedures and surge in technical advances.
Market Segmentation
The MRFR study has outlined various aspects of the urology devices market share for enhanced understanding, shedding light on major segments like types, applications, technology, and end users.
Different types of urology devices available in the industry are endoscopy devices, urinary incontinence & pelvic organ prolapsed devices, urinary stone treatment devices, benign prostatic hyperplasia treatment devices, dialysis equipment, and more.
Urology devices’ top applications are Prostate Cancer, Urinary Incontinence, Urinary Stones, as well as Benign Prostatic Hyperplasia. Urinary stones occur in 1 in every 20 individuals, with the major reasons being diabetes, high blood pressure, and history of kidney failure. As a result, urology devices market insights are witnessing enormous demand for treating urinary stones, cases of which have been escalating rapidly worldwide.
Technology-wise, the segments are minimally invasive surgery, robotic surgery, and more.
End-users listed are ambulatory services, hospitals, and more.
Regional Analysis
The urology devices industry has been regionally considered for APAC/Asia Pacific, MEA/Middle East & Africa, the Americas, and Europe.
America maintains its winning streak and will continue to do so throughout the evaluation timeframe, thanks to the escalating cases of kidney stones, traumatic injury, prostate cancer, and others. The American Urological Association Foundation confirms that benign prostatic hyperplasia (BPH), urinary incontinence (UI), urinary tract infections, and kidney and ureteral stones are the top urological ailments occurring in the region.
Asia Pacific could be the fastest progressing market in the next few years, on account of the booming population with significant unmet medical needs and the surge in economic standards. Mounting cases of Benign Prostatic Hyperplasia (BPH) as well as Urinary Tract Infection (UTI) also raises the demand for urology devices.
Top Companies
The top urology devices manufacturers in the market are C. R. Bard Inc. (US), Boston Scientific Corporation (US), Stryker (US), Olympus Corporation (Japan), HealthTronics, Inc (US), KARL STORZ GmbH & Co. KG (Germany), NIKKISO CO. LTD (Japan), Medtronic (US), Dornier MedTech (Germany), Fresenius Medical Care AG & Co. KGaA (Germany), Cook (US), and many more.
These contenders expend huge amounts on research and development (R&D) for product innovation as well as new launches, which helps them gain a higher share in the worldwide industry. They also use strategies such as acquisitions, FDA approvals, collaborations, expansions, and joint ventures, among others.
For instance, in May 2021, Olympus Corporation acquired Medi-Tate Ltd., an Israeli medical device firm. The acquisition is projected to bolster Olympus’s position in the urological devices market, also bolstering its product offering for the treatment of benign prostatic hyperplasia (BPH) treatment.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Overview
The Cancer Diagnostics Market Size was assessed at USD 160.2 billion in 2021 and is expected to rise from USD 170.9 billion in 2022 to USD 269.1 billion by 2030, with a compound yearly growth rate (CAGR) of 6.70% during the forecast period (2022- 2030). We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Top Boosters and Barriers
Cancer remains of the most common reasons for deaths worldwide and the alarming rate at which it is gaining prevalence is one of the factors that boost the market demand. Given the aggravating situation, healthcare specialists are increasing their focus on developing advanced diagnostic solutions to analyze the prevalence level.
Technological innovations in several fields including imaging, biomarkers, endoscopy; biopsy, and the rapidly expanding geriatric population also work in the cancer diagnostics market’s favor. Rising number of initiatives by the government bodies and the increasing funds being allocated in this field also fosters market growth.
Many of the top firms in the global market are able to sustain their positions by adopting strategies such as product innovations and rigorous R&D efforts for the introduction of the same. It is expected that the competition in the worldwide market could intensify substantially over the next few years, as several vendors are now more focused on carrying out researches and coming up with innovative diagnostic techniques via product range expansions, acquisitions, collaborations and mergers. To illustrate, in November 2020, NanoString Technologies collaborated with the Oregon Health & Science University for the development of GeoMx Digital Spatial Profiler-based protein assays that cater to patients with breast cancer. This product innovation is expected to boost the application range of spatial biology, with the bigger picture being improved patient care via modern molecular testing.
Market Segmentation
Cancer diagnostics market outlook can be categorized depending on type, application and end user.
The types of cancer diagnostics trend in the market are biomarkers testing, imaging testing, biopsy, in vitro diagnostic testing, and more. Imaging testing types such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scan are non-invasive, pain-free and quick diagnostic solutions and therefore, observe significant demand in the healthcare industry.
Some of the top market applications are breast cancer, lung cancer, melanoma cancer, colorectal cancer, liver cancer, prostate cancer, and others.
Research institutes, hospitals and clinics, diagnostic centers, and others are the key market end-users.
Regional Insight
Asia Pacific or APAC, the Americas, Middle East & Africa or MEA and Europe are the primary markets for cancer diagnostics.
America is currently leading the global market for cancer diagnostics, thanks to the burgeoning elderly population and the high healthcare spending.
Since 2018, Europe has remained the second biggest market for cancer diagnostics, as a result of the mounting awareness level among people about cancer and the surge in technological advances in the oncology field. Germany is the frontrunner in the regional Cancer Diagnostics Market report, considering that the country has a massive patient pool and accommodates a huge population of highly skilled healthcare professionals.
APAC could record the highest growth rate in the ensuing years, given that the region holds a vast cancer-afflicted population and this has bolstered the need for more effective diagnostics.
Top Industry Contenders
Top industry contenders analyzed in the MRFR report include Biotheranostics, Illumina, Inc., Exact Sciences Corporation, QIAGEN N.V., Arquer Diagnostics Ltd, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Roche Diagnostics, Siemens Healthcare, GE Healthcare, Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Koninklijke Philips N.V., Inc., BioMark Diagnostics Inc., Cancer Diagnostics, Inc., to name a few.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com
Market Overview
The Cancer Diagnostics Market Size was assessed at USD 160.2 billion in 2021 and is expected to rise from USD 170.9 billion in 2022 to USD 269.1 billion by 2030, with a compound yearly growth rate (CAGR) of 6.70% during the forecast period (2022- 2030). We will provide COVID-19 impact analysis with the report, along with all the extensive key developments in the market post the coronavirus disease outbreak.
Top Boosters and Barriers
Cancer remains of the most common reasons for deaths worldwide and the alarming rate at which it is gaining prevalence is one of the factors that boost the market demand. Given the aggravating situation, healthcare specialists are increasing their focus on developing advanced diagnostic solutions to analyze the prevalence level.
Technological innovations in several fields including imaging, biomarkers, endoscopy; biopsy, and the rapidly expanding geriatric population also work in the cancer diagnostics market’s favor. Rising number of initiatives by the government bodies and the increasing funds being allocated in this field also fosters market growth.
Many of the top firms in the global market are able to sustain their positions by adopting strategies such as product innovations and rigorous R&D efforts for the introduction of the same. It is expected that the competition in the worldwide market could intensify substantially over the next few years, as several vendors are now more focused on carrying out researches and coming up with innovative diagnostic techniques via product range expansions, acquisitions, collaborations and mergers. To illustrate, in November 2020, NanoString Technologies collaborated with the Oregon Health & Science University for the development of GeoMx Digital Spatial Profiler-based protein assays that cater to patients with breast cancer. This product innovation is expected to boost the application range of spatial biology, with the bigger picture being improved patient care via modern molecular testing.
Market Segmentation
Cancer diagnostics market outlook can be categorized depending on type, application and end user.
The types of cancer diagnostics trend in the market are biomarkers testing, imaging testing, biopsy, in vitro diagnostic testing, and more. Imaging testing types such as Magnetic Resonance Imaging (MRI) and Computed Tomography (CT) scan are non-invasive, pain-free and quick diagnostic solutions and therefore, observe significant demand in the healthcare industry.
Some of the top market applications are breast cancer, lung cancer, melanoma cancer, colorectal cancer, liver cancer, prostate cancer, and others.
Research institutes, hospitals and clinics, diagnostic centers, and others are the key market end-users.
Regional Insight
Asia Pacific or APAC, the Americas, Middle East & Africa or MEA and Europe are the primary markets for cancer diagnostics.
America is currently leading the global market for cancer diagnostics, thanks to the burgeoning elderly population and the high healthcare spending. The well-developed healthcare industry also favors the American market, especially in the United States.
Since 2018, Europe has remained the second biggest market for cancer diagnostics, as a result of the mounting awareness level among people about cancer and the surge in technological advances in the oncology field. Germany is the frontrunner in the regional Cancer Diagnostics Market report, considering that the country has a massive patient pool and accommodates a huge population of highly skilled healthcare professionals.
Top Industry Contenders
Top industry contenders analyzed in the MRFR report include Biotheranostics, Illumina, Inc., Exact Sciences Corporation, QIAGEN N.V., Arquer Diagnostics Ltd, Abbott Laboratories, Inc., Thermo Fisher Scientific, Inc., Roche Diagnostics, Siemens Healthcare, GE Healthcare, Agilent Technologies, Inc., Becton, Dickinson and Company (BD), Koninklijke Philips N.V., Inc., BioMark Diagnostics Inc., Cancer Diagnostics, Inc., to name a few.
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.
Contact Us:
Market Research Future (Part of Wantstats Research and Media Private Limited)
99 Hudson Street, 5Th Floor
New York, NY 10013
United States of America
+1 628 258 0071 (US)
+44 2035 002 764 (UK)
Email: [email protected]
Website: https://www.marketresearchfuture.com